INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Building A Resilient Supply Chain For Your Next-Generation Peptide Therapeutic

  As peptide therapeutics continue to establish themselves as a leading technology for treating chronic indications, drug sponsors must identify reliable peptide building block suppliers to secure high-quality starting materials.

• Biopharma Supply, Reimagined: Regional, Resilient Manufacturing

  Persistent disruption is redefining biopharma supply chains. Explore how regional manufacturing, integrated risk management, and closer collaboration help build resilience and improve agility.

• Site Transfer Of Tablet Production From Ex-U.S. To Georgia Site

  Explore how strategic U.S.-based manufacturing and supply chain diversification can reduce risk, lower costs, and enhance supply reliability for pharmaceutical products.

• How To Select The Right Fill-Finish CDMO For Phase I–II

  Early‑phase programs require flexible, technically aligned fill‑finish partners. Mid‑sized CDMOs offer a balance of agility, infrastructure, and regulatory maturity suited to Phase I–II needs.

• How To Save Significantly On Early-Phase Clinical Supply

  5/6/2026

  Discover how integrated clinical supply strategies streamline early trials, reduce logistics complexity, cut costs, and ensure timely delivery of investigational products and samples.

• Supply Chain Efficiency And Sourcing In Gene Therapy

  11/4/2025

  An overview of the inbound supply chain in gene therapy and the process development challenges that are frequently faced. Learn about concepts such as scaling, cell culture media sourcing, mixing technologies, and configurable packaging.

• Four Reasons You Should Choose Lyophilization for Your Next Project

  12/10/2025

  Lyophilization ensures product stability, extends shelf life, supports sensitive formulations, and simplifies storage and transport, making it a critical choice for modern drug development projects.

• Friendshoring: A Strategic Shift In Pharma Supply Chains

  4/11/2025

  To safeguard the consistent delivery of essential therapies to patients around the world, biopharmaceutical companies, alongside their CDMO partners, are rethinking traditional supply models.

• Global Strategies For Resilience And Redundancy In Cell Culture Media Supply

  7/17/2025

  Ensure your cell culture media supply remains uninterrupted. Explore proactive strategies for global manufacturing equivalency and consistent media delivery.